Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease

International Wound Journal

Volumn 12, Issue 3, 2015, Pages 250-253

  de Franciscis, Stefano ^a   Gallelli, Luca ^a   Battaglia, Luigi ^b   Molinari, Vincenzo ^a   Montemurro, Rossella ^a   Stillitano, Domenico M ^a   Buffone, Gianluca ^a   Serra, Raffaele ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Gastroenterology   (Italy)

Author keywords

Cilostazol; Diabetic foot; Intermittent claudication; Metalloproteinase 9; Peripheral vascular disease

Indexed keywords

CILOSTAZOL; GELATINASE B; TETRAZOLE DERIVATIVE; VASODILATOR AGENT;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLAUDICATION; DIABETIC FOOT; DIABETIC PATIENT; DIARRHEA; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE DISEASE; OPEN STUDY; PARALLEL DESIGN; PARESTHESIA; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN TINGLING; STUFFY NOSE; TACHYCARDIA; TREATMENT DURATION; WEAKNESS; BLOOD; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYMOLOGY; FOOT ULCER; INTERMITTENT CLAUDICATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FOOT ULCER; HUMANS; INTERMITTENT CLAUDICATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RETROSPECTIVE STUDIES; TETRAZOLES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84929263990     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12085     Document Type: Article

References (16)

1. Mackaay AJ, Beks PJ, Dur AH, Bischoff M, Scholma J, Heine RJ, Rauwerda JA. The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects. Eur J Vasc Endovasc Surg 1995;9:170-5.
2. Zubair M, Malik A, Ahmad J. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. Foot (Edinb) 2012;22:24-30.
3. Heikkinen M, Salmenperä M, Lepäntalo A, Lepäntalo M. Diabetes care for patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 2007;33:583-91.
4. Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJV. Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments. Diabetes Metab 2004;30:549-56.
5. Serra R, Buffone G, Dominijanni A, Molinari V, Montemurro R, de Franciscis S. Applicationif platelet-rich gel to enhance healing of transmetatarsal amputaions in diabetic dysvascular patients. Int Wound J 2013. DOI: 10.1111/iwj.12052.
6. Hiatt WR. The US experience with cilostazol in treating intermittent claudication. Atheroscler Suppl 2005;6:21-31.
7. O'Donnell ME, Badger SA, Sharif MA, Makar RR, Young IS, Lee B, Soong CV. The effects of cilostazol on peripheral neuropathy in diabetic patients with peripheral arterial disease. Angiology 2008;59:695-704.
8. Papanas N, Maltezos E. Cilostazol in diabetic neuropathy: premature farewell or new beginning? Angiology 2011;62:605-8.
9. Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L, de Franciscis S. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Rep Reg 2013. DOI: 10.1111/wrr.12035.
10. Serra R, Gallelli L, Buffone G, Molinari V, Stillitano DM, Palmieri C, de Franciscis S. Doxycycline speeds up healing of chronic venous ulcers. Int Wound J 2013. DOI: 10.1111/iwj.12077.
11. Chuang SY, Yang SH, Chen TY, Pang JH. Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells. Eur J Pharmacol 2011;670:419-26.
12. Li Z, Guo S, Yao F, Zhang Y, Li T. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers. J Diabetes Complications 2013. DOI: 10.1016/j.jdiacomp.2012.12.007.
13. Biscetti F, Pecorini G, Straface G, Arena V, Stigliano E, Rutella S, Locatelli F, Angelini F, Ghirlanda G, Flex A. Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism. Int J Cardiol 2012. DOI: 10.1016/j.ijcard.2012.03.103.
14. Russo E, Donato di Paola E, Gareri P, Siniscalchi A, Labate A, Gallelli L, Citraro R, De Sarro G. Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res 2012;70:1-12.
15. Pelaia G, Gallelli L, Renda T, Fratto D, Falcone D, Caraglia M, Busceti MT, Terracciano R, Vatrella A, Maselli R, Savino R. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells. Cell Prolif 2012 Dec;45:557-65.
16. Gallelli L, Gioffrè V, Vero G, Gallelli A, Roccia F, Naty S, Pelaia G, Capano A, Loiacono A, De Sarro G, Maselli R. Clarithromycin in the treatment of Legionella pneumophila pneumonia associated with multiorgan failure in a previously healthy patient. Clin Drug Investig 2005;25:485-90.